ES
Eos SENOLYTIX, Inc.
SEC filingPharmaceuticals · Houston, TX
Amount raised$750Ksold at filing
Total offering$25M$24.3M still open
Investors in the raise2count reported to the SEC
FiledAug 27, 2026first sale Jun 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jerold Bartlett WinogradDirector
Kevin Mark SlawinExecutive Officer, Director
Frank Bartlett McGuyerDirector
Executive officers, directors and promoters as listed on the Form D.